SARS-CoV-2 virus and our smoke evacuation system maXium® smart Vac and marVac®
This is a promise we have pursued in surgery since 1923. With this claim in mind, we develop and market medical technology solutions such as implant systems, electrosurgery units, surgical laser systems, sterilization containers, OR lights, surgical instruments as well as individual OR solutions. And in many cases, we have set new benchmarks.More about us
In the course of his summer tour, Baden-Württemberg's Minister President Winfried Kretschmann visited us today together with District Administrator Stefan Baer, Lord Mayor Michael Beck and representatives of the Ministry of State and Medical Mountains. Under the motto "Digitalization and Individualization in Medical Technology", the joint product development with clinical users, challenges of the European Medical Device Directive for medicine and medium-sized companies as well as the shortage of skilled workers in rural areas were discussed.
After treated radius fractures, in some cases malposition occurs which can lead to reduced strength, pain and decreased mobility. Similar limitations can be also seen in congenital malposition cases. Besides the standard treatment of radius malunion, we also offer patient-specific solutions for the distal radius reconstruction.
After a 15-month construction period and a previous intensive 18-month planning phase, the new production and construction building of Karl Leibinger Medizintechnik GmbH & Co. KG (part of the KLS Martin Group) in Mühlheim on the Danube was inaugurated. Just in time before the summer holidays, the final work was completed and the machinery and workplaces were moved.
With effect of May 1st, 2020, the Mühlheim-based medical technology company Karl Leibinger has taken over the major business operations of Stuckenbrock Medizintechnik and its shares in the company Gebrüder Martin. All Stuckenbrock employees, the relevant production equipment and the products distributed by Gebrüder Martin will be taken over. The location in Lessingstraße in Tuttlingen will also be retained. Business operations will be conducted under the new company name KLS Martin Medical GmbH & Co. KG.
Burkina Faso only counts six paediatric surgeons taking care of 7.2 million children. These figures are exemplary for the country's health system. The association "Operieren in Afrika e.V." which translates to "performing surgeries in Africa" is carrying out several projects to improve interdisciplinary medical care.
Last year we founded KLS Martin de México S.A. de C.V based in Mexico City to support our local distributors in marketing and sales of our products within the Latin American market.
We opened a new planning office for our Individual Patient Solutions (IPS®) in Cardiff, United Kingdom. The new company, KLS Martin IPS® Service UK Limited, has been launched to bring a more personal and local service to UK clinicians and to give them more in-depth knowledge of our patient-specific solutions.
About 40 distributors from all over the world found their way to our KLS Martin WORLD in Tuttlingen for this year's "Implant Knowledge CMF" training course.
In today's electrosurgery, safe and easy handling combined with efficiency and innovative technology are among the main requirements in the operating room. For this reason, our Expert Meeting in cooperation with Sharjah University of the United Arab Emirates and the Indo German Endoscopy and Laparoscopic Society (IGELS) focused on bipolar vessel sealing.
Overall, the Tuttlingen-based KLS Martin Group is very pleased with the course of the past fiscal year. In 2019, the family-run medical technology company generated worldwide sales of EUR 300 million for the first time. Global sales growth amounted to almost 10%, which is a very good growth rate compared to the international industry.
Ten years ago we founded Gebrüder Martin in Shanghai. Initially as a representative office. Seven years later, we converted it into a subsidiary. Since then, the company has been operating under the name of KLS Martin Medical (Shanghai) International Trading Co, Ltd. and has been pushing the marketing and sales of our products in China. And with success.
For the first time, 25 renowned hand surgeons from eleven countries met for an international exchange of experts with our engineers, planners, product managers and specialists discussing the use of patient-specific implants in hand and forearm surgery.
Find out about what is making our marLED® X special, what the advantages are for the various user groups and what the future holds in the interview.
The KLS Martin Group is foregoing the Christmas present for customers and business partners and is supporting the regional German Child Protection Association in Tuttlingen with a donation of 10,000 euros this year.
For fifteen years now, our group companies have been operating under the name KLS Martin Group. We take this as an opportunity to present figures, facts and individual milestones of this period.
IPS Implants® Hand includes patient-specific reconstruction of the distal radius and forearm (radius and/or ulna). Our experts Christoph, Ines and Johannes report in an interview on the indications for which IPS Implants® Hand is suitable and the experience gained by first clinical users.
The topic of handing over a company is on everyone's lips, especially in medium-sized businesses. Karl and Christian Leibinger, Presidents of the KLS Martin Group, also dealt with this topic. Today, Karl Leibinger can look back on a successful handover of the company.
Today we officially opened our KLS Martin WORLD North America training center at our site in Jacksonville, Florida. After a construction period of 14 months, the training center finally joins our North American campus, which previously included our marketing and sales company KLS Martin LP as well as our development and production company KLS Martin Manufacturing LLC.
After only six months of construction, the topping-out ceremony for the extension at Karl Leibinger Medizintechnik (KLM) in Mühlheim an der Donau was celebrated. The shell of all the concrete work has now been completed on schedule. With an expected investment sum of 13 million euros, the new building is the largest single investment in the company's more than 100-year history.